STATCenter·
STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
Roche has inked a drug discovery deal with Chinese biotech Defand Therapeutics, focused on molecular glue medicines.
Read at STAT →
Health · 1 sources covering this
STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
Roche has inked a drug discovery deal with Chinese biotech Defand Therapeutics, focused on molecular glue medicines.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/71f2393fe44f6eb3cac7f97bf8e9eb9d791ed6a5" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines"></iframe>
